The Research Committee at RCSI Bahrain holds the budget to facilitate the development of research within the institution. The committee aims to fund as many projects as is feasible, while also offering diversity in the types of project funded.
RCSI Bahrain has continued to spend in excess of the national requirement of expenditure on research (3% of net income) and, from 2018, aspires to meet the requirement of 3% of total income. There is a strong commitment to providing financial support for research, funding resources include internal grants, collaborations with the Arabian Gulf University (AGU) and the University of Bahrain (UoB), in addition to the RCSI Bahrain Research Summer School.
The research grant allocation for 2015/16 was BHD 64,000, it was BHD 53,000 for 2016/17 and BHD 57,000 for 2017/18. These figures include the joint Arabian Gulf University (AGU) fund of BHD 10,000 for each university, as well as the student summer research support each year.
The 2014/15 internal research funding supported the following major projects:
- Sound evoked muscle reflexes;
- Examining Hunter-Schreger bands in tooth enamel;
- Tissue engineering and adipose derived stem cells;
- Use of nanoparticles to measure blood glucose and curcumin derivatives and breast cancer;
- Inflammatory markers and other factors in sickle cell disease.
The 2015/16 internal research funding sustained the following projects:
- Studies on the use of nano particles and stem cells as novel anti-cancer agents;
- Attitudes to organ donations; auditory discrimination performance;
- The use of curcumin in otosclerosis;
- Investigating sigma receptors as novel targets for cancer therapy.
The internal research grants in 2016/17 encompassed the following areas:
- Synthesis and antimicrobial activity of nano particles;
- Determining the regulation and function of inositol phosphates;
- Knowledge and attitudes of men in Bahrain towards prostate cancer study
- Elucidation of the role of curcumin on potassium channels in breast cancer cells
- Duocarmycin functionalized gold nanoparticles and breast cancer
- Design and synthesis of novel selective FLT-3 kinase inhibitors as anticancer agents